The serotonin transporter gene locus in late-life major depressive disorder

Davide Seripa, Francesco Panza, Grazia D'Onofrio, Giulia Paroni, Alessandra Bizzarro, Andrea Fontana, Francesco Paris, Leandro Cascavilla, Massimiliano Copetti, Carlo Masullo, Alberto Pilotto

Research output: Contribution to journalArticle

Abstract

Objective: Polymorphism C in the solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 (SLC6A4) gene has been variously associated with major depressive disorder (MDD). To the best of our knowledge, no data were reported regarding a role of SLC6A4 in late-life MDD. The aim of this study was to explore the possible involvement of the SLC6A4 locus in patients with late-life MDD by means of a haplotype-tagged approach. Design: Case-control study. Setting: Older patients attending a geriatric unit. Participants: A total of 218 patients with late-life MDD (61 men and 157 women) age 65 to 92 years (76.29 ± 6.53 years) and 363 depression-free healthy subjects (156 men and 207 women) age 41 to 65 years (48.33 ± 5.94 years). Measurements: Genotyping and haplotype estimation of the three markers rs4795541, rs140701, and rs3813034 spanning a 39-kb block the SLC6A4 locus. Diagnoses of late-life MDD, mild cognitive impairment, Alzheimer disease, vascular dementia, and other dementing diseases were made using current clinical criteria. Results: No significant differences were observed in allele or genotype distribution for the three SLC6A4 markers across the study groups. Because the comparison group could not be matched for age, a sensitivity analysis for the misclassification of controls was performed according to different scenarios. For each simulated scenario, the same nonsignificant result was observed. However, the results are limited to late-life MDD that is specifically not associated with cognitive impairment, and there was limited power for detecting very small effect sizes. Conclusions: Our findings suggested that the SLC6A4 locus play a minor role, if any, in the pathogenesis of late-life MDD. Also, tempering our conclusions, we were unable to account for population stratification, recurrence or chronicity of depression, nor the influence of coexisting medical, cognitive, and psychosocial stressors.

Original languageEnglish
Pages (from-to)67-77
Number of pages11
JournalAmerican Journal of Geriatric Psychiatry
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 2013

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Major Depressive Disorder
Genes
Haplotypes
Neurotransmitter Transport Proteins
Depression
Vascular Dementia
Delayed Diagnosis
Geriatrics
Case-Control Studies
Serotonin
Healthy Volunteers
Alzheimer Disease
Alleles
Genotype
Recurrence
Population

Keywords

  • Late-life MDD
  • Major depression
  • Serotonin
  • Serotonin transporter
  • SLC6A4

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology

Cite this

The serotonin transporter gene locus in late-life major depressive disorder. / Seripa, Davide; Panza, Francesco; D'Onofrio, Grazia; Paroni, Giulia; Bizzarro, Alessandra; Fontana, Andrea; Paris, Francesco; Cascavilla, Leandro; Copetti, Massimiliano; Masullo, Carlo; Pilotto, Alberto.

In: American Journal of Geriatric Psychiatry, Vol. 21, No. 1, 01.2013, p. 67-77.

Research output: Contribution to journalArticle

Seripa, Davide ; Panza, Francesco ; D'Onofrio, Grazia ; Paroni, Giulia ; Bizzarro, Alessandra ; Fontana, Andrea ; Paris, Francesco ; Cascavilla, Leandro ; Copetti, Massimiliano ; Masullo, Carlo ; Pilotto, Alberto. / The serotonin transporter gene locus in late-life major depressive disorder. In: American Journal of Geriatric Psychiatry. 2013 ; Vol. 21, No. 1. pp. 67-77.
@article{ce3acd5df73d444d91e48f4f797833c8,
title = "The serotonin transporter gene locus in late-life major depressive disorder",
abstract = "Objective: Polymorphism C in the solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 (SLC6A4) gene has been variously associated with major depressive disorder (MDD). To the best of our knowledge, no data were reported regarding a role of SLC6A4 in late-life MDD. The aim of this study was to explore the possible involvement of the SLC6A4 locus in patients with late-life MDD by means of a haplotype-tagged approach. Design: Case-control study. Setting: Older patients attending a geriatric unit. Participants: A total of 218 patients with late-life MDD (61 men and 157 women) age 65 to 92 years (76.29 ± 6.53 years) and 363 depression-free healthy subjects (156 men and 207 women) age 41 to 65 years (48.33 ± 5.94 years). Measurements: Genotyping and haplotype estimation of the three markers rs4795541, rs140701, and rs3813034 spanning a 39-kb block the SLC6A4 locus. Diagnoses of late-life MDD, mild cognitive impairment, Alzheimer disease, vascular dementia, and other dementing diseases were made using current clinical criteria. Results: No significant differences were observed in allele or genotype distribution for the three SLC6A4 markers across the study groups. Because the comparison group could not be matched for age, a sensitivity analysis for the misclassification of controls was performed according to different scenarios. For each simulated scenario, the same nonsignificant result was observed. However, the results are limited to late-life MDD that is specifically not associated with cognitive impairment, and there was limited power for detecting very small effect sizes. Conclusions: Our findings suggested that the SLC6A4 locus play a minor role, if any, in the pathogenesis of late-life MDD. Also, tempering our conclusions, we were unable to account for population stratification, recurrence or chronicity of depression, nor the influence of coexisting medical, cognitive, and psychosocial stressors.",
keywords = "Late-life MDD, Major depression, Serotonin, Serotonin transporter, SLC6A4",
author = "Davide Seripa and Francesco Panza and Grazia D'Onofrio and Giulia Paroni and Alessandra Bizzarro and Andrea Fontana and Francesco Paris and Leandro Cascavilla and Massimiliano Copetti and Carlo Masullo and Alberto Pilotto",
year = "2013",
month = "1",
doi = "10.1016/j.jagp.2012.10.012",
language = "English",
volume = "21",
pages = "67--77",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - The serotonin transporter gene locus in late-life major depressive disorder

AU - Seripa, Davide

AU - Panza, Francesco

AU - D'Onofrio, Grazia

AU - Paroni, Giulia

AU - Bizzarro, Alessandra

AU - Fontana, Andrea

AU - Paris, Francesco

AU - Cascavilla, Leandro

AU - Copetti, Massimiliano

AU - Masullo, Carlo

AU - Pilotto, Alberto

PY - 2013/1

Y1 - 2013/1

N2 - Objective: Polymorphism C in the solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 (SLC6A4) gene has been variously associated with major depressive disorder (MDD). To the best of our knowledge, no data were reported regarding a role of SLC6A4 in late-life MDD. The aim of this study was to explore the possible involvement of the SLC6A4 locus in patients with late-life MDD by means of a haplotype-tagged approach. Design: Case-control study. Setting: Older patients attending a geriatric unit. Participants: A total of 218 patients with late-life MDD (61 men and 157 women) age 65 to 92 years (76.29 ± 6.53 years) and 363 depression-free healthy subjects (156 men and 207 women) age 41 to 65 years (48.33 ± 5.94 years). Measurements: Genotyping and haplotype estimation of the three markers rs4795541, rs140701, and rs3813034 spanning a 39-kb block the SLC6A4 locus. Diagnoses of late-life MDD, mild cognitive impairment, Alzheimer disease, vascular dementia, and other dementing diseases were made using current clinical criteria. Results: No significant differences were observed in allele or genotype distribution for the three SLC6A4 markers across the study groups. Because the comparison group could not be matched for age, a sensitivity analysis for the misclassification of controls was performed according to different scenarios. For each simulated scenario, the same nonsignificant result was observed. However, the results are limited to late-life MDD that is specifically not associated with cognitive impairment, and there was limited power for detecting very small effect sizes. Conclusions: Our findings suggested that the SLC6A4 locus play a minor role, if any, in the pathogenesis of late-life MDD. Also, tempering our conclusions, we were unable to account for population stratification, recurrence or chronicity of depression, nor the influence of coexisting medical, cognitive, and psychosocial stressors.

AB - Objective: Polymorphism C in the solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 (SLC6A4) gene has been variously associated with major depressive disorder (MDD). To the best of our knowledge, no data were reported regarding a role of SLC6A4 in late-life MDD. The aim of this study was to explore the possible involvement of the SLC6A4 locus in patients with late-life MDD by means of a haplotype-tagged approach. Design: Case-control study. Setting: Older patients attending a geriatric unit. Participants: A total of 218 patients with late-life MDD (61 men and 157 women) age 65 to 92 years (76.29 ± 6.53 years) and 363 depression-free healthy subjects (156 men and 207 women) age 41 to 65 years (48.33 ± 5.94 years). Measurements: Genotyping and haplotype estimation of the three markers rs4795541, rs140701, and rs3813034 spanning a 39-kb block the SLC6A4 locus. Diagnoses of late-life MDD, mild cognitive impairment, Alzheimer disease, vascular dementia, and other dementing diseases were made using current clinical criteria. Results: No significant differences were observed in allele or genotype distribution for the three SLC6A4 markers across the study groups. Because the comparison group could not be matched for age, a sensitivity analysis for the misclassification of controls was performed according to different scenarios. For each simulated scenario, the same nonsignificant result was observed. However, the results are limited to late-life MDD that is specifically not associated with cognitive impairment, and there was limited power for detecting very small effect sizes. Conclusions: Our findings suggested that the SLC6A4 locus play a minor role, if any, in the pathogenesis of late-life MDD. Also, tempering our conclusions, we were unable to account for population stratification, recurrence or chronicity of depression, nor the influence of coexisting medical, cognitive, and psychosocial stressors.

KW - Late-life MDD

KW - Major depression

KW - Serotonin

KW - Serotonin transporter

KW - SLC6A4

UR - http://www.scopus.com/inward/record.url?scp=84875417292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875417292&partnerID=8YFLogxK

U2 - 10.1016/j.jagp.2012.10.012

DO - 10.1016/j.jagp.2012.10.012

M3 - Article

C2 - 23290204

VL - 21

SP - 67

EP - 77

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 1

ER -